|
![]() | |||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
September 2014 Volume 14 Number 9 | |||||||||||||||||||||||||||||||||||||
| In this issue![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
| ||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing Sarah L. Gaffen, Renu Jain, Abhishek V. Garg & Daniel J. Cua p585 | doi:10.1038/nri3707 T helper 17 (TH17) cells promote protective immune responses against infection, particularly at barrier sites, but they can also have pathogenic roles in inflammatory diseases. In this Review, the authors describe the factors that control the development and maintenance of TH17 cells, and discuss their diverse functions in both health and disease. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
A long-awaited merger of the pathways mediating host defence and programmed cell death J. Magarian Blander p601 | doi:10.1038/nri3720 There is a growing appreciation of how the host inflammatory response is intricately entwined with the various forms of programmed cell death. This Review discusses the signalling mechanisms that link these processes, with a particular focus on how the key mediators of cell death, such as the caspases, are integrated into innate signalling modules. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
ANALYSIS | Top | ||||||||||||||||||||||||||||||||||||
Phenotypic models of T cell activation Melissa Lever, Philip K. Maini, P. Anton van der Merwe & Omer Dushek p619 | doi:10.1038/nri3728 There is currently no single model that fits the wealth of experimental data that relate T cell activation to T cell receptor-peptide-MHC binding parameters. Here, the authors analyse and reformulate the published models, and suggest that a kinetic proofreading model that involves limited T cell receptor signalling provides the best fit. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||
OPINION Interactions between innate and adaptive lymphocytes Georg Gasteiger & Alexander Y. Rudensky p631 | doi:10.1038/nri3726 Recent evidence indicates that adaptive T cell-mediated immune responses can regulate innate lymphocytes (natural killer cells and innate lymphoid cells) in an interleukin-2-dependent manner. The authors propose a model in which adaptive T cells function as peripheral antigen-specific sensors that recruit and activate innate lymphocytes to amplify and coordinate local immune responses. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
OPINION Natural killer T cells: drivers or passengers in preventing human disease? Stuart P. Berzins & David S. Ritchie p640 | doi:10.1038/nri3725 Natural killer T (NKT) cell defects have been implicated in several diseases such as autoimmunity, asthma and cancer, but will targeting them really be of clinical benefit? Here, the authors investigate this question and conclude that more careful studies are needed before the true clinical potential of NKT cell-targeted therapies can be determined. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
![]() |
*2013 Journal Citation Report (Thomson Reuters, 2014) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |
No comments:
Post a Comment